lysine has been researched along with Cerebral Gigantism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aref-Eshghi, E; Bonder, MJ; Choufani, S; Martin-Herranz, DE; Reik, W; Sadikovic, B; Stegle, O; Stubbs, TM; Thornton, JM; Weksberg, R | 1 |
| Aoki, S; Hatada, I; Hidaka, H; Higashimoto, K; Horii, T; Kimura, M; Maeda, T; Matsumoto, N; Miyake, N; Morita, S; Okamoto, N; Soejima, H; Suzuki, T; Uemura, T; Watanabe, H; Yatsuki, H | 1 |
2 other study(ies) available for lysine and Cerebral Gigantism
| Article | Year |
|---|---|
Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1.
Topics: Adult; Aging; Biological Clocks; CpG Islands; DNA Methylation; Entropy; Epigenesis, Genetic; Genetic Testing; Genome, Human; Histone-Lysine N-Methyltransferase; Histones; Humans; Infant; Lysine; Models, Genetic; Sotos Syndrome | 2019 |
DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
Topics: Child; Child, Preschool; CRISPR-Cas Systems; DNA Methylation; Enhancer Elements, Genetic; Epigenome; Female; Gene Deletion; Genomic Imprinting; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Infant; Infant, Newborn; Insulin-Like Growth Factor II; Lysine; Male; Phenotype; Point Mutation; Promoter Regions, Genetic; Sotos Syndrome | 2020 |